论文部分内容阅读
目的探讨基于规范的子宫内膜癌个体优化治疗效果。方法选取我院2012年5月~2016年3月收治的68例子宫内膜癌患者作为研究对象,采取规范的个体优化治疗,观察子宫内膜癌患者的治疗恢复情况。结果在68例子宫内膜癌患者当中,其治疗有效率为77.94%(43/68),其中保守治疗、手术治疗以及化疗/放疗的治疗有效率分别为80%、79.07%和73.33%,差异无统计学意义(P>0.05)。其并发症发生率和复发率分别为36.76%(25/68)和19.12%(13/68),其中保守治疗、手术治疗以及化疗/放疗的并发症发生率分别为10%、34.88%和60%,复发率分别为10%、16.28%以及33.33%,差异有统计学意义(P<0.05)。结论基于规范的子宫内膜癌个体优化治疗,能够根据患者的实际病情,采取恰当的治疗方法,能够获得理想的治疗效果。
Objective To investigate the optimal treatment of endometrial cancer based on norms. Methods Sixty-eight patients with endometrial cancer who were treated in our hospital from May 2012 to March 2016 were selected as the research object. The patients were treated with standard optimization and the recovery of the treatment of endometrial cancer was observed. Results Among the 68 patients with endometrial cancer, the effective rate was 77.94% (43/68). The effective rates of conservative treatment, surgical treatment and chemotherapy / radiotherapy were 80%, 79.07% and 73.33% respectively. The difference was significant No statistical significance (P> 0.05). The complication rates and recurrence rates were 36.76% (25/68) and 19.12% (13/68), respectively. The complication rates of conservative treatment, surgical treatment and chemotherapy / radiotherapy were 10%, 34.88% and 60% respectively %, The recurrence rates were 10%, 16.28% and 33.33%, respectively, the difference was statistically significant (P <0.05). Conclusion Based on the standardized optimization of individual endometrial cancer treatment, according to the actual condition of the patient, take the appropriate treatment, to obtain the desired effect of treatment.